A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

Na Shen, Fei Yan, Jiuxia Pang, Lai Chu Wu, Aref Al-Kali, Mark R Litzow, Shujun Liu

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Nucleolin overexpression and DNA hypermethylation have been implicated in cancer pathogenesis, but whether and how these aberrations cooperate in controlling leukemia cell fate remain elusive. Here, we provide the first mechanistic insights into the role of nucleolin in leukemogenesis through creating a DNA hypermethylation profile in leukemia cells. We found that, in leukemia patients, nucleolin levels are significantly elevated and nucleolin overexpression strongly associates with DNMT upregulation and shorter survival. Enforced nucleolin expression augmented leukemia cell proliferation, whereas nucleolin dysfunction by RNA interference and inhibitory molecule AS1411 blocked leukemia cell clonogenic potential in vitro and impaired tumorigenesis in vivo. Mechanistic investigations showed that nucleolin directly activates NFκB signaling, and NFκB activates its downstream effector, DNA methylation machinery. Indeed, nucleolin overexpression increased NFκB phosphorylation and upregulated DNMT1 that is followed by DNA hypermethylation; by contrast, nucleolin dysfunction dephosphorylated NFκB and abrogated DNMT1 expression, which resulted in decreased global DNA methylation, restored p15INK4B expression and DNA hypomethylation on p15INK4B promoter. Notably, NFκB inactivation diminished, whereas NFκB overexpression enhanced DNMT1 promoter activity and endogenous DNMT1 expression. Collectively, our studies identify nucleolin as an unconventional epigenetic regulator in leukemia cells and demonstrate nucleolin-NFκB-DNMT1 axis as a new molecular pathway underlying AML leukemogenesis.

Original languageEnglish (US)
Pages (from-to)5494-5509
Number of pages16
JournalOncotarget
Volume5
Issue number14
StatePublished - 2014

Fingerprint

Leukemia
DNA
DNA Methylation
nucleolin
RNA Interference
Epigenomics
Carcinogenesis
Up-Regulation
Phosphorylation
Cell Proliferation
Survival
Neoplasms

Keywords

  • DNA methylation
  • DNA methyltransferase
  • Leukemia
  • Nucleolin

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Shen, N., Yan, F., Pang, J., Wu, L. C., Al-Kali, A., Litzow, M. R., & Liu, S. (2014). A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis. Oncotarget, 5(14), 5494-5509.

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis. / Shen, Na; Yan, Fei; Pang, Jiuxia; Wu, Lai Chu; Al-Kali, Aref; Litzow, Mark R; Liu, Shujun.

In: Oncotarget, Vol. 5, No. 14, 2014, p. 5494-5509.

Research output: Contribution to journalArticle

Shen, N, Yan, F, Pang, J, Wu, LC, Al-Kali, A, Litzow, MR & Liu, S 2014, 'A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis', Oncotarget, vol. 5, no. 14, pp. 5494-5509.
Shen N, Yan F, Pang J, Wu LC, Al-Kali A, Litzow MR et al. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis. Oncotarget. 2014;5(14):5494-5509.
Shen, Na ; Yan, Fei ; Pang, Jiuxia ; Wu, Lai Chu ; Al-Kali, Aref ; Litzow, Mark R ; Liu, Shujun. / A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis. In: Oncotarget. 2014 ; Vol. 5, No. 14. pp. 5494-5509.
@article{7b0f1239c88749b7a49c6b9f4a3d0fe2,
title = "A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis",
abstract = "Nucleolin overexpression and DNA hypermethylation have been implicated in cancer pathogenesis, but whether and how these aberrations cooperate in controlling leukemia cell fate remain elusive. Here, we provide the first mechanistic insights into the role of nucleolin in leukemogenesis through creating a DNA hypermethylation profile in leukemia cells. We found that, in leukemia patients, nucleolin levels are significantly elevated and nucleolin overexpression strongly associates with DNMT upregulation and shorter survival. Enforced nucleolin expression augmented leukemia cell proliferation, whereas nucleolin dysfunction by RNA interference and inhibitory molecule AS1411 blocked leukemia cell clonogenic potential in vitro and impaired tumorigenesis in vivo. Mechanistic investigations showed that nucleolin directly activates NFκB signaling, and NFκB activates its downstream effector, DNA methylation machinery. Indeed, nucleolin overexpression increased NFκB phosphorylation and upregulated DNMT1 that is followed by DNA hypermethylation; by contrast, nucleolin dysfunction dephosphorylated NFκB and abrogated DNMT1 expression, which resulted in decreased global DNA methylation, restored p15INK4B expression and DNA hypomethylation on p15INK4B promoter. Notably, NFκB inactivation diminished, whereas NFκB overexpression enhanced DNMT1 promoter activity and endogenous DNMT1 expression. Collectively, our studies identify nucleolin as an unconventional epigenetic regulator in leukemia cells and demonstrate nucleolin-NFκB-DNMT1 axis as a new molecular pathway underlying AML leukemogenesis.",
keywords = "DNA methylation, DNA methyltransferase, Leukemia, Nucleolin",
author = "Na Shen and Fei Yan and Jiuxia Pang and Wu, {Lai Chu} and Aref Al-Kali and Litzow, {Mark R} and Shujun Liu",
year = "2014",
language = "English (US)",
volume = "5",
pages = "5494--5509",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "14",

}

TY - JOUR

T1 - A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

AU - Shen, Na

AU - Yan, Fei

AU - Pang, Jiuxia

AU - Wu, Lai Chu

AU - Al-Kali, Aref

AU - Litzow, Mark R

AU - Liu, Shujun

PY - 2014

Y1 - 2014

N2 - Nucleolin overexpression and DNA hypermethylation have been implicated in cancer pathogenesis, but whether and how these aberrations cooperate in controlling leukemia cell fate remain elusive. Here, we provide the first mechanistic insights into the role of nucleolin in leukemogenesis through creating a DNA hypermethylation profile in leukemia cells. We found that, in leukemia patients, nucleolin levels are significantly elevated and nucleolin overexpression strongly associates with DNMT upregulation and shorter survival. Enforced nucleolin expression augmented leukemia cell proliferation, whereas nucleolin dysfunction by RNA interference and inhibitory molecule AS1411 blocked leukemia cell clonogenic potential in vitro and impaired tumorigenesis in vivo. Mechanistic investigations showed that nucleolin directly activates NFκB signaling, and NFκB activates its downstream effector, DNA methylation machinery. Indeed, nucleolin overexpression increased NFκB phosphorylation and upregulated DNMT1 that is followed by DNA hypermethylation; by contrast, nucleolin dysfunction dephosphorylated NFκB and abrogated DNMT1 expression, which resulted in decreased global DNA methylation, restored p15INK4B expression and DNA hypomethylation on p15INK4B promoter. Notably, NFκB inactivation diminished, whereas NFκB overexpression enhanced DNMT1 promoter activity and endogenous DNMT1 expression. Collectively, our studies identify nucleolin as an unconventional epigenetic regulator in leukemia cells and demonstrate nucleolin-NFκB-DNMT1 axis as a new molecular pathway underlying AML leukemogenesis.

AB - Nucleolin overexpression and DNA hypermethylation have been implicated in cancer pathogenesis, but whether and how these aberrations cooperate in controlling leukemia cell fate remain elusive. Here, we provide the first mechanistic insights into the role of nucleolin in leukemogenesis through creating a DNA hypermethylation profile in leukemia cells. We found that, in leukemia patients, nucleolin levels are significantly elevated and nucleolin overexpression strongly associates with DNMT upregulation and shorter survival. Enforced nucleolin expression augmented leukemia cell proliferation, whereas nucleolin dysfunction by RNA interference and inhibitory molecule AS1411 blocked leukemia cell clonogenic potential in vitro and impaired tumorigenesis in vivo. Mechanistic investigations showed that nucleolin directly activates NFκB signaling, and NFκB activates its downstream effector, DNA methylation machinery. Indeed, nucleolin overexpression increased NFκB phosphorylation and upregulated DNMT1 that is followed by DNA hypermethylation; by contrast, nucleolin dysfunction dephosphorylated NFκB and abrogated DNMT1 expression, which resulted in decreased global DNA methylation, restored p15INK4B expression and DNA hypomethylation on p15INK4B promoter. Notably, NFκB inactivation diminished, whereas NFκB overexpression enhanced DNMT1 promoter activity and endogenous DNMT1 expression. Collectively, our studies identify nucleolin as an unconventional epigenetic regulator in leukemia cells and demonstrate nucleolin-NFκB-DNMT1 axis as a new molecular pathway underlying AML leukemogenesis.

KW - DNA methylation

KW - DNA methyltransferase

KW - Leukemia

KW - Nucleolin

UR - http://www.scopus.com/inward/record.url?scp=84906244425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906244425&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 5494

EP - 5509

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 14

ER -